Four stroke survivors who did not take part in the focus group will be recruited from the follow-up clinic to take part in a one-to-one pilot interview to ascertain the feasibility of the study method. Again, feedback will be sought from the pilot interviewees on the questions and the way the study was run, Dizocilpine MK 801 and final amendments to the full study will be made accordingly. Participants in the pilot and main study will be offered the

opportunity to validate the transcription by checking a copy of their interview for accuracy. This will give participants ownership of the data and further allow them to agree to its use. Participants will also be given a copy of the final report, to see the results of their involvement. Ethical considerations The study proposal has been reviewed

by the West Midlands South Comprehensive Local Research Network, and been peer-reviewed by an independent university lecturer who acted as a reviewer. All study documentation has been reviewed by the Coventry and Warwickshire Research Ethics Committee and the chief investigator met with the committee to scrutinise the study and justify its methodology. The committee has approved this study. Risk of breach of confidentiality will be minimised by the use of anonymised data. Participants will be asked to consent to direct quotations from interview being used in the final report, in the knowledge that they will not be named or their identity be inferred. There is a minimal risk that people might become upset while talking about their experiences of stroke; FP is an experienced interviewer and will support people appropriately using active listening skills. People will not have to answer any questions they find uncomfortable and can withdraw at any time in the study; this will be made clear in the consent process. In the event

of an individual becoming distressed, they will be asked if they wish to delay or discontinue the interview, and FP will ensure that someone is with the participant once the interview is completed. The interviewer will also be equipped to provide the participant with GSK-3 details of support organisations or help-lines should the need arise. Anticipated problems There might be a bias caused by the participant receiving additional attention by taking part in the interview; they might over-value the clinic appointment because additional attention has been paid to them and they place value on that process. Participants will be reminded that the focus of the study is the value of the clinic appointment, so as not to confound the results. Individuals may be reluctant to offer negative views about the clinic if they are aware that those views will be fed back to the consultant.